NEW YORK – One Drop has received clearance from the U.S. Food and Drug Administration, as well as CE Mark approval, for the One Drop/Chrome, a blood glucose monitoring system.
“One Drop is designed by people with diabetes for people with diabetes, and One Drop/Chrome is a perfect embodiment of our vision,” said Jeff Dachis, One Drop CEO and founder, in a statement.
One Drop/Chrome is available as part of One Drop/Premium, the first monthly subscription service to provide affordable, accessible diabetes care, unlimited blood glucose testing supplies and 24/7 live in-app support.
With One Drop/Mobile’s seamless user experience and deep data integration, users have contributed more than 100 million health data points, logging in more than 2 million times to the app, which tracks blood glucose, medication, food and physical activity.
A recent analysis of data showed that users: consistently tracked their food and blood glucose over time; increased their average number of in-range blood glucose readings by 40%; reduced their average percentage of high blood glucose readings from 18.5% to 3.7%; and reduced their average blood glucose value from 185 mg/dL to 158 mg/dL.
“We’re transforming the diabetes management experience by designing empowering, beautiful products people love to use while also delivering outstanding evidence-based results,” said Dachis.